ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

“5 A Day” Review Underway to Check Program’s Health at NCI.

March 31, 2000

Zeneca Buys 50% Stake In Salick, Gets Managed Care Access

January 6, 1995

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

In Brief: Melanoma Precursors Consensus Conference Planned, DRCC Board Raps Centers Budget Cut

May 20, 1983